BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21439107)

  • 1. Cognitive and emotional behavioural changes associated with methylphenidate treatment: a review of preclinical studies.
    Britton GB
    Int J Neuropsychopharmacol; 2012 Feb; 15(1):41-53. PubMed ID: 21439107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of anxiety-related responses in male rats following prolonged exposure to therapeutic doses of oral methylphenidate.
    Britton GB; Bethancourt JA
    Pharmacol Biochem Behav; 2009 Oct; 93(4):451-9. PubMed ID: 19540871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
    Ince Tasdelen B; Karakaya E; Oztop DB
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically-oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS.
    Monden Y; Dan H; Nagashima M; Dan I; Kyutoku Y; Okamoto M; Yamagata T; Momoi MY; Watanabe E
    Clin Neurophysiol; 2012 Jun; 123(6):1147-57. PubMed ID: 22088661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental strategies for investigating psychostimulant drug actions and prefrontal cortical function in ADHD and related attention disorders.
    Agster KL; Clark BD; Gao WJ; Shumsky JS; Wang HX; Berridge CW; Waterhouse BD
    Anat Rec (Hoboken); 2011 Oct; 294(10):1698-712. PubMed ID: 21901844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate normalizes emotional processing in adult patients with attention-deficit/hyperactivity disorder: preliminary findings.
    Conzelmann A; Woidich E; Mucha RF; Weyers P; Jacob CP; Lesch KP; Pauli P
    Brain Res; 2011 Mar; 1381():159-66. PubMed ID: 21215727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies.
    Linssen AM; Sambeth A; Vuurman EF; Riedel WJ
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):961-77. PubMed ID: 24423151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.
    Williams LM; Hermens DF; Palmer D; Kohn M; Clarke S; Keage H; Clark CR; Gordon E
    Biol Psychiatry; 2008 May; 63(10):917-26. PubMed ID: 18272140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to oral methylphenidate from adolescence through young adulthood produces transient effects on hippocampal-sensitive memory in rats.
    Bethancourt JA; Camarena ZZ; Britton GB
    Behav Brain Res; 2009 Aug; 202(1):50-7. PubMed ID: 19447280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomic hypoactivity in boys with attention-deficit/hyperactivity disorder and the influence of methylphenidate.
    Conzelmann A; Gerdes AB; Mucha RF; Weyers P; Lesch KP; Bähne CG; Fallgatter AJ; Renner TJ; Warnke A; Romanos M; Pauli P
    World J Biol Psychiatry; 2014 Jan; 15(1):56-65. PubMed ID: 24410179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder.
    Frölich J; Banaschewski T; Döpfner M; Görtz-Dorten A
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1169-83. PubMed ID: 24856438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of developmental exposure to methylphenidate on rat brain's immune privilege and behavior: Control versus ADHD model.
    Coelho-Santos V; Cardoso FL; Leitão RA; Fontes-Ribeiro CA; Silva AP
    Brain Behav Immun; 2018 Feb; 68():169-182. PubMed ID: 29061363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
    Denney CB
    J Clin Child Psychol; 2001 Mar; 30(1):98-109. PubMed ID: 11294083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC; Nutt DJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder.
    Prehn-Kristensen A; Krauel K; Hinrichs H; Fischer J; Malecki U; Schuetze H; Wolff S; Jansen O; Duezel E; Baving L
    Brain Res; 2011 May; 1388():56-68. PubMed ID: 21385569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response.
    Pearson DA; Lane DM; Santos CW; Casat CD; Jerger SW; Loveland KA; Faria LP; Mansour R; Henderson JA; Payne CD; Roache JD; Lachar D; Cleveland LA
    J Am Acad Child Adolesc Psychiatry; 2004 Jun; 43(6):686-98. PubMed ID: 15167085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.
    Kubas HA; Backenson EM; Wilcox G; Piercy JC; Hale JB
    Postgrad Med; 2012 Sep; 124(5):33-48. PubMed ID: 23095424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate regulates c-fos and fosB expression in multiple regions of the immature rat brain.
    Chase TD; Carrey N; Brown RE; Wilkinson M
    Brain Res Dev Brain Res; 2005 Apr; 156(1):1-12. PubMed ID: 15862622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.